Rafferty Asset Management
IMVT icon

Rafferty Asset Management’s Immunovant IMVT Stock Holding History

Rafferty Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75M Sell
71,430
-65,189
-48% -$1.99M 0.01% 566
2026
Q1 		$3.39M Buy
136,619
+4,273
+3% +$111K 0.01% 495
2025
Q4 		$3.36M Buy
132,346
+30,483
+30% +$680K 0.01% 534
2025
Q3 		$1.64M Sell
101,863
-4,607
-4% -$74.6K 0.01% 691
2025
Q2 		$1.7M Sell
106,470
-32,367
-23% -$489K 0.01% 642
2025
Q1 		$2.37M Buy
138,837
+22,213
+19% +$465K 0.01% 530
2024
Q4 		$2.89M Sell
116,624
-35,723
-23% -$1.01M 0.01% 537
2024
Q3 		$4.34M Buy
152,347
+11,649
+8% +$344K 0.01% 456
2024
Q2 		$3.71M Sell
140,698
-148,687
-51% -$4.23M 0.01% 481
2024
Q1 		$9.35M Buy
289,385
+60,298
+26% +$2.2M 0.03% 287
2023
Q4 		$9.65M Sell
229,087
-67,745
-23% -$2.49M 0.04% 292
2023
Q3 		$11.4M Buy
296,832
+45,211
+18% +$1.02M 0.07% 192
2023
Q2 		$4.77M Sell
251,621
-76,295
-23% -$1.42M 0.03% 423
2023
Q1 		$5.09M Buy
327,916
+97,343
+42% +$1.69M 0.03% 380
2022
Q4 		$4.09M Buy
+230,573
New +$2.9M 0.03% 418
2022
Q1 		– Sell
-189,926
Closed -$1.62M – 1272
2021
Q4 		$1.62M Buy
189,926
+610
+0.3% +$5.04K 0.01% 738
2021
Q3 		$1.65M Sell
189,316
-17,873
-9% -$161K 0.01% 686
2021
Q2 		$2.19M Buy
207,189
+11,091
+6% +$155K 0.01% 661
2021
Q1 		$3.15M Buy
196,098
+179,130
+1,056% +$4.72M 0.02% 457
2020
Q4 		$784K Sell
16,968
-4,567
-21% -$211K 0.01% 575
2020
Q3 		$758K Buy
+21,535
New +$648K 0.01% 619

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rafferty Asset Management's IMVT Position: Q2 2026 in Review

Rafferty Asset Management reduced its Immunovant (IMVT) stake by 48% in Q2 2026, selling an estimated $1.99M and leaving 71,430 shares worth $2.75M. The position accounts for 0.01% of the portfolio, ranked #566.

Rafferty Asset Management first reported a position in IMVT in Q3 2020 and has held it in 21 quarters since. The position peaked at $11.4M in Q3 2023. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Rafferty Asset Management held 71,430 shares of Immunovant worth $2.75M as of Q2 2026.
  • Rafferty Asset Management sold 65,189 Immunovant shares in Q2 2026, an estimated $1.99M.
  • Immunovant made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #566 holding.
  • Rafferty Asset Management first reported a position in Immunovant in Q3 2020 and has held it in 21 quarters since.
  • Rafferty Asset Management's Immunovant position peaked at $11.4M in Q3 2023.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.